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Context: Depression is a highly prevalent and debilitating mental disorder, particularly among 
patients under hemodialysis, who are more susceptible to depression due to their complex 
treatment regimens, dietary limitations, side effects of medications and fear of disease 
outcomes. This systematic review and meta-analysis explored the prevalence of depression in 
Iranian hemodialysis patients. 
Evidence Acquisitions: In this systematic review and meta-analysis, search was done in national 
and international databases, including SID, MagIran, Google Scholar, Web of Science, 
Medline (via PubMed), and Scopus from inception to March 2018. Key search terms included 
hemodialysis, renal replacement therapy, dialysis, end-stage renal disease, renal failure, 
depression and Iran along with all their possible combinations. Data were combined for meta-
analysis using random effects model. Heterogeneity between studies was analyzed by I2 test, 
and data were analyzed by STATA (version 12) software. 
Results: The included 24 articles had a sample size of 2941 participants; the overall prevalence 
of depression in hemodialysis patients in Iran was 56.8% (95% CI: 50.5-63). The results of 
the univariate meta-regression analysis showed no significant correlation between prevalence 
of depression and methodological quality of articles (P = 0.524), duration of hemodialysis 
(P = 0.885), publication year (P = 0.116), mean age of participants (P = 0.224) and sample size 
(P = 0.194). 
Conclusions: More than half of the hemodialysis patients in Iran suffer from depression. Given 
the overlap of depression symptoms with uremia in this group of patients, it is necessary to 
identify depression in these patients for early management and interventions.  
ABSTRACT
Implication for health policy/practice/research/medical education:
Depression is common in patients undergoing hemodialysis, with an estimated prevalence of  56.8%. The presence of 
depressive symptoms could potentially decrease patient’s medication adherence and hence leads to increased morbidity and 
mortality. Therefore, it is necessary for the healthcare team to always consider the symptoms of  depression in hemodialysis 
patients to identify people at early stages and thus plan appropriate management care plan for better and effective outcomes. 
Please cite this paper as: Abdi A, Dalvand S, Vahedian-Azimi A, Ghanei Gheshlagh R, Kurdi A. Prevalence of  depression 
among Iranian patients under hemodialysis: a systematic review and meta-analysis. J Nephropathol. 2018;7(4):224-232. DOI: 
10.15171/jnp.2018.47.
1. Context
Chronic kidney disease is a silent illness that is often 
undiagnosed until at advanced stages, when the only 
treatment option is dialysis or kidney transplantation 
(1). Globally, the prevalence of  end-stage renal disease 
(ESRD) is increasing, and it is doubled every 7 years (2). 
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In Iran, 38 000 patients are undergoing hemodialysis 
every year, and this number is estimated to be doubled 
by 2020 (3). 
Management of  ESRD requires strict lifestyle dietary 
changes and pharmacological regimens as well as 
commitments to regular attendance to hemodialysis 
sessions. Therefore, these patients face limitations in 
their social life, career, finances and independence (4). 
Furthermore, hemodialysis patients are susceptible to 
developing emotional problems due the chronic stress 
related to their disease burden, dietary and functional 
limitations, some of  which are well-known risk factors 
for depression which include: (5) Fatigue, sleep disorder, 
treatment limitations, changes in family roles and social 
communications, limited daily activities, uncertainty about 
the future, unemployment, dependence on healthcare 
professionals and reduced sexual performance (6). 
Due to high prevalence of  mental disorders in hemodialysis 
patients, Levy used the term psychonephrology to 
introduce this disorder in patients with hemodialysis or 
renal failure (7). However, early diagnosis  and assessment 
of  depression is difficult in this patient group because 
depression and uremic symptoms overlap each other 
(5, 6). The interaction between chronic renal disease 
and depression is dynamic and multifactorial, given the 
common risk factors and biopsychosocial consequences 
of  both illnesses, including similar biological changes in 
the immune system, inflammatory pathways, disruption 
of  the hypothalamic-pituitary axis and sympathetic and 
parasympathetic changes (8). 
Early diagnosis of  depression in this patient group is 
essential since depression is reported to be associated 
with poor quality of  life, increased re-hospitalization, 
cardiovascular diseases, malnutrition (6) and importantly, 
non-compliance with treatment (9) in hemodialysis 
patients. Mortality rate and non-compliance with 
treatment in hemodialysis patients suffering from 
depression are two to three times more than hemodialysis 
patients without depression (10). Previous studies in Iran 
reported conflicting results about the true prevalence 
of  depression in hemodialysis patients, with prevalence 
ranging from 28% to 93% (11,12). Therefore, this study 
aimed to estimate the true prevalence of  depression in 
hemodialysis patients in Iran using systematic search of 
literature. This is crucial because any strategy to prevent 
and mange depression in this group of  patients requires 
accurate estimation of  the size of  the problem; hence 
appropriate allocation of  healthcare resources. 
2. Evidence Acquisitions
This study was a systematic review and meta-analysis, 
of  studies reporting the prevalence of  depression in 
hemodialysis patients in Iran, published in Persian or 
English in national and international journals, from 
inception to March 2018. The SID, Magiran, Google 
Scholar, Web of  Science, Medline (via PubMed), and 
Scopus data-banks were searched using the following key 
terms: hemodialysis, renal replacement therapy, dialysis, 
end-stage renal disease, renal failure, depression and Iran. 
Furthermore, the reference lists of  the identified articles 
were also searched to identify any relevant studies. 
2.1. Study selection and data extraction
All observational studies reporting the prevalence of 
depression in hemodialysis patients in Iran were included 
in the study. In cases where the prevalence of  depression 
was compared between hemodialysis and kidney-
transplant patients, the data of  hemodialysis patients 
were extracted from the articles. The exclusion criteria 
comprised of  articles not relevant to the subject, case 
reports, interventional studies, repeated studies and lack 
of  access to the full-text articles. 
To decrease bias, articles were screened independently by 
two researchers, and in the case of  disagreement, another 
author who was an expert in meta-analysis reviewed 
the article. Then, the required data, including title, first 
author, publication year, study location, sample size, type 
of  questionnaire, mean age, mean duration of  dialysis 
and prevalence of  depression were extracted from 
the articles. Articles were then screened and selected 
according to the Preferred Reporting Items for Systematic 
Reviews and Meta-analysis (PRISMA) guidelines (13). 
The methodological quality of  the articles was assessed 
using quality of  life scale tool, which has been previously 
using in various studies. This tool consists of  five items, 
including study design, comparison group, description of 
study samples, sample size and data collection. Each item 
is given a score of  0 to 3; with a higher score indicating a 
higher methodological quality (14-16). 
2.2. Statistical analysis 
Since prevalence has a binominal distribution, the 
variance of  prevalence was calculated by the binomial 
distribution variance formula, and the mean weight 
was used to combine the prevalence rate of  the various 
studies. To assess the heterogeneity of  the selected studies, 
Cochran’s Q and I2 tests were applied (heterogeneities 
were classified into three categories, including <25% 
(low heterogeneity), 25-75% (moderate heterogeneity) 
and >75% (high heterogeneity). Considering the 
heterogeneity of  studies and significant I2 index, random 
effects model was used to combine the studies and 
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estimate the combined prevalence. Meta-regression 
analysis was performed to estimate the correlation of 
depression prevalence with the year of  conducting the 
study and sample size, and analysis of  subgroups was 
carried out to determine the prevalence rate of  the five 
regions separately. Egger’s test and Funnel plot were used 
to analyze publication bias. Sensitivity analysis was done 
by excluding a study one at a time. Data were analyzed 
by STATA software (version 12) and metan command. 
3. Results 
A total of  368 articles were identified from the initial 
search, 24 of  which were included in the final analysis 
based on the inclusion and exclusion criteria (Figure 1). 
The studies selected for meta-analysis were examined 
in terms of  sensitivity. The results showed exclusion of 
articles did not change the total estimate of  prevalence 
of  depression. To make sure all studies conducted on 
depression in hemodialysis patients in Iran were included 
in the study or not, the bias graph was used. The results 
of  Egger’s regression analysis showed no significant 
publication bias (P = 0.948) (Figure 2).
A total of  24 articles with a total sample size of  2941 
participants and a mean of  123 participants in each study 
were reviewed in this study. The maximum and minimum 
sample sizes were found for the studies by Nouruzi et al 
(n=310) (3) and Hashemi et al (n=46) (17), respectively. 
With regard to methodological quality, all the included 
studies were of  moderate quality apart from two studies, 
one of  which was poor and the other one was good. The 
general characteristics of  the studies chosen for meta-
analysis are shown in Table 1.
Overall, the prevalence of  depression in hemodialysis 
patients was reported to be 56.8% (95% CI: 50.5-63) 
(Figure 3). The maximum and minimum prevalence 
rates of  depression were found for a study carried out 
in Sanandaj (93%) (11), and one performed in Tehran 
(28%).
The findings of  different depression screening tools 
showed the highest prevalence rates of  depression in 
hemodialysis patients for the Center for Epidemiologic 
Studies Depression Scale (CES-D) and Depression 
Anxiety Stress Scale (DASS) (prevalence rate of  62%, 
95% CI: 57-68) and Beck’s Depression Inventory (BDI) 
(prevalence of  60%, 95% CI: 52-69). A total of  14 
studies had used BDI. The results for the five regions 
of  the country indicated the maximum and minimum 
prevalence rates of  depression in hemodialysis patients 
for the region three (prevalence rate of  78%, 95% CI: 
47-108) and region two (prevalence rate of  53%, 95% 
CI: 46-60), respectively (Figure 4). The prevalence of 
depression in the articles published in Persian language 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097 
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Figure 1. Screening and selecting the articles for meta-analysis based on PRISMA guidelines.
Journal of  Nephropathology, Vol 7, No 4, October 2018                                                                                                                                                  www.nephropathol.com227
Abdi et al
Table 1. Characteristics of  the studies selected for meta-analysis
No. First author Year Sample size Mean age Scale Location Prevalence of depression
Mean duration of 
hemodialysis (month)
Score of 
quality
1 Norozi Firoz (3) 2016 310 59.6±13.9 BDI Mazandaran 44.8 39.8±42.5 9
2 Najafi (18) 2016 127 55.7±17.5 HADS Tehran 31.5 - 8
3 Ekramzadeh (19) 2015 110 47.8±14.8 BDI Shiraz 62 34.5±3.81 8
4 Anjomshoa (20) 2014 217 - BDI Kerman 57.4 - 7
5 Salehi (21) 2014 60 - HADS Mahabad 62 - 6
6 Hashemi (17) 2014 46 - BDI Shirvan 39.2 - 6
7 Osareh (9) 2014 150 56.4±16.4 BDI Tehran 40.7 - 7
8 Bakhtiari (22) 2013 70 - HADS Tehran 64.3 - 4
9 Bayat (23) 2012 218 58.2±14.3 HADS Isfahan 43.1 - 6
10 Sanavi (24) 2012 120 57.5±15.7 BDI Tehran 70 5.42±3.36 6
11 Ahmadzadeh (25) 2012 196 - SCL-90 Isfahan 50 - 5
12 Taraz (26) 2012 83 57.4±15.7 BDI Tehran 61.4 71.1±57.3 11
13 Mogharab (27) 2011 60 54.4±17.5 BDI Birjand 56.7 - 8
14 Roozbeh (28) 2011 196 - SCL-90 Isfahan 50 - 6
15 Mahmoudi (11) 2010 61 47.4±15.5 BDI Sanandaj 93 - 6
16 Afshar (29) 2010 120 57.6±15.3 BDI Tehran 70 36.3±42.5 5
17 Mollahadi (30) 2010 147 39.3±11.7 DASS Tehran 60.5 - 9
18 Masoudi Alavi (31) 2009 63 55.3±14.5 SCL-90 Kashan 65.3 30.3±36.8 8
19 Tavallaii (12) 2009 68 55.1±14.2 HADS Tehran 27.9 - 8
20 Nazemian (32) 2008 150 30.1±2.91 CES-D Mashhad 64.5 - 10
21 Raeisi (33) 2005 80 52.9±17.7 BDI Tehran 60 55.9±56.6 4
22 Modanlou (34) 2005 129 - BDI Gorgan 68.2 - 7
23 Zahir aldin (35) 2005 100 - BDI Tehran 69 - 5
24 Salehi (36) 2003 60 - BDI Tehran 50 - 4
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(prevalence rate of  63%, 95% CI: 56-71) was higher than 
that of  articles published in English language (prevalence 
rate of  50%, 95% CI: 43-57). More details are illustrated 
in Table 2.
The results of  the univariate meta-regression analysis 
showed no correlation between depression prevalence 
and methodological quality of  articles (P = 0.524), age 
of  samples (P = 0.224) and duration of  hemodialysis 
(P = 0.885). The prevalence of  depression experienced 
a descending trend with an increase in the publication 
year (P = 0.116) and sample size (P = 0.194), but these 
changes were not statistically significant (Figure 5).
4. Discussion 
In this meta-analysis, the prevalence of  depression in 
Figure 2. Publication bias in the studied articles. Circles show the 
weight of  studies.
Figure 3. Forest plot of  depression prevalence in hemodialysis 
patients. The confidence interval 95% for each study is shown 
as horizontal lines around the mean; dotted lines in the middle 
indicate total mean score and diamonds show the prevalence 
range of  this disorder.
Iranian hemodialysis patients was 56.8% (95% CI: 50.5-
63), which is higher than the prevalence rate reported 
for the U.S. (20%), Malaysia (36.6%) and China (29%) 
(37-39). Other studies have shown higher prevalence of 
depression in hemodialysis patients in neighborhood 
countries such as Iraq (80%), Pakistan (75%) and 
Saudi Arabia (63%) than in Iran (40-42). This variation 
could potentially be due to cultural, social and hygienic 
differences of  the mentioned countries. 
A study in 2015 showed a higher prevalence of  depression 
in people with low education and socioeconomic status 
(43). Further, another study confirmed the association 
of  depression with absence of  appropriate physical 
activity (44). Since hemodialysis patients in Iran undergo 
critical conditions with regard to socioeconomic status, 
unemployment after the illness, stresses to access 
the required equipment and treatments (45) and lack 
of  proper physical activity (46), high prevalence of 
depression is justifiable. Moreover, another issue that 
is quite important in hemodialysis patients is perceived 
social support in these patients. Patients with high 
social support experience less depression (47). Based 
on the studies carried out in Iran, considering the 
changing cultural and social conditions of  the present 
age, less social support is provided to patients with 
chronic diseases (48), which is a potential risk factor for 
depression. Shahgholian et al reported that hemodialysis 
patients need spiritual, mental and physical support from 
the people around them and others’ mere condolence 
was of  no benefit to them. However, because of  the 
social stigma of  chronic disease for these patients and 
their families, their social communication is disrupted 
and families disregard and conceal the presence of 
hemodialysis patient to reduce the emotional load of  this 
phenomenon and its effect on the future of  the other 
members of  the family, resulting in potential rejection 
of  the patient by others and intensification of  mental 
disorders in these patients (49). 
In their meta-analysis, Mirzaei et al reported a prevalence 
rate of  63% (95% CI: 56-70) for depression in Iranian 
hemodialysis patients during 1998-2013, which indicates 
a descending trend for depression in hemodialysis 
patients in the recent years in comparison with the results 
of  the present study. This meta-regression analysis 
also confirmed the correlation of  depression with 
publication year (50). This declining trend in depression 
prevalence could be related to increased knowledge of 
people, increased health knowledge and more access 
to health facilities. The systematic review and meta-
analysis of  Palmer et al, also indicated a prevalence of 
30% for depression among patients under hemodialysis, 
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which is lower than the prevalence rate of  depression in 
hemodialysis patients in Iran (51). Further, the systematic 
review and meta-analysis of  Murtagh et al, showed a 
prevalence rate of  27% (95% CI: 5-58) for depression in 
hemodialysis patients (52). 
High prevalence of  depression in hemodialysis patients 
can be due to the overlap of  physical symptoms of 
depression such as sleep disorder, anorexia, fatigue, 
sexual dysfunction and digestive disorders with uremia 
(41). On the other hand, depression is often undiagnosed 
in hemodialysis patients. Johnston believes that the 
symptoms of  more than 70% of  depressed hemodialysis 
patients are not diagnosed, or these patients are not 
referred to the healthcare centers for drug therapy or 
psychotherapy (53). One of  the reasons for less attention 
of  healthcare providers to depression in hemodialysis 
Table 2. The prevalence of  depression in hemodialysis patients
Groups No. of  Studies Sample size Prevalence (%) 95% CI HeterogeneityI2 Q P
Scale
BDI 14 1646 60 52-69 92.9 183.29 0.0001
HADS 5 543 45 32-58 89.6 38.51 0.0001
SCL-90 3 455 54 46-62 63.8 5.53 0.063
DASS & CES 2 297 62 57-68 0 0.51 0.476
Language
Persian 13 1271 63 56-71 89.6 115.73 0.0001
English 11 1669 50 43-57 89.4 94.55 0.0001
Region
1 13 1564 55 47-63 91.1 135.43 0.0001
2 5 783 53 46-60 76.5 17.03 0.002
3 2 121 78 48-103 94.8 19.24 0.0001
5 4 56 56 47-64 68.9 9.66 0.022
Region 1: Alborz, Tehran, Qazvin, Mazandaran, Semnan, Golestan, and Gom; Region 2: Esfahan, Fars, Bushehr, Hormozgan, Kohgiluyeh 
and Boyer-Ahmad, and Chaharmahal and Bakhtiari; Region 3: West Azerbaijan, East Azerbaijan, Ardabil, Zanjan, Gilan, and Kurdistan;  
Region 5: Razavi Khorasan, North Khorasan, South Khorasan, Kerman, Yazd, and Sistan and Baluchestan
Figure 4. Prevalence of  depression in hemodialysis patients for 
different provinces of  Iran. Circles show provinces in which only 
one study has been done and squares indicate those with more 
than one study.
Figure 5. Prevalence of  depression in hemodialysis patients according to sample size (A) and the publication year of  studies (B). Circles 
show the weight of  studies.
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patients is the low mood of  these patients, which is due 
to the nature of  their illness (42). 
The findings of  the five regions of  the country showed 
the highest prevalence of  depression (78%) for the 
hemodialysis patients of  region three (two studies 
in Sanandaj and Mahabad). This difference could be 
attributed to the cultural characteristics of  the people in 
this region, climatic conditions and access to healthcare 
services. The results of  the study by Riolo et al indicated 
that prevalence of  depression was not influenced by 
ethnicity and race (54). Some differences reported the 
previous studies are because of  the different screening 
tools of  depression being used. The results for separate 
tools showed the highest prevalence of  depression for 
the articles that had used DASS, CES (62%) and BDI 
(60%). The lowest prevalence rate of  depression was 
found in the studies that had used hospital anxiety and 
depression scale (HADS) (45%). Hospital anxiety and 
depression scale, with 14 items, analyses two dimensions, 
including depression and anxiety, and the final score is 
influenced by both depression status and anxiety status 
of  the patient; whereas, BDI, with 21 items, focuses 
exclusively on affective, cognitive and physical aspects of 
depression. Comprehensive and updated presentation 
of  depression prevalence in Iranian hemodialysis 
patients was one of  the strengths of  the current study. A 
limitation of  this study was lack of  access to the full text 
of  several studies and low quality of  some studies that 
had not reported the essential details of  their research. 
5. Conclusions
In general, the findings of  this study showed that more 
than half  of  hemodialysis patients had the symptoms 
of  depression. Considering the overlap of  depression 
symptoms with uremia in these patients, diagnosis 
of  depression in these patients is more difficult, and 
depression in these patients may be undiagnosed or 
may be diagnosed wrongly. The presence of  depression 
as an underlying illness along with dietary limitations 
and tough treatment regimens could result in reduced 
quality of  life and increased mortality in these patients. 
Knowledge of  depression prevalence in hemodialysis 
patients can help the healthcare authorities to design 
programs and strategies to prevent, control and treat this 
disorder more effectively. 
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